%0 Generic
%T Response to letter to the editor : switch to dolutegravir and unboosted atazanavir switch to dolutegravir and unboosted atazanavir
%A Di Biagio, Antonio
%A Magnasco, Laura
%A Cenderello, Giovanni
%A Rizzardini, Giuliano
%I Ovid Technologies (Wolters Kluwer Health)
%@ 0269-9370
%K Infectious Diseases
%K Immunology
%K Immunology and Allergy
%D 2019
%C Ovid Technologies (Wolters Kluwer Health)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation